SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Acutaas Chemicals’ arm buys 75% stake in JV company in South Korea

12 Feb 2026 Evaluate

Acutaas Chemicals’ wholly owned subsidiary -- Acutaas Advance Material (previously known as Baba Advance Materials) has acquired 75% of shareholding in the joint venture company (JV company), Indichem Inc. Pursuant to this, Indichem Inc. has become a step-down subsidiary of the company.  The 300,000 shares representing 75% of shareholding in Indichem Inc. have been acquired at par value of 500 South Korean won per share fully paid, plus partly paid applicable share premium amount.

Indichem Inc is into the business of manufacture of speciality chemicals for semiconductor industry catering to South Korean and Global Market. The acquisition of shareholding in JV company is in line with the growth strategy of Acutaas Advance Material for expansion into the speciality chemicals for semiconductor industry in the global market significantly complementing its existing product portfolio. 

Earlier in June 2025, Baba Advance Materials (BAML) has entered into a joint venture agreement with J & Materials Co., a South Korean company, whereby BAML shall hold 75% of the share capital of the JV company -- Indichem Inc., a South Korean company and the remaining 25% of the share capital of the JV company will be held by J & Materials Co.

Acutaas Chemicals (formally knowns as Ami Organics) is one of the leading research and development driven manufacturers of specialty chemicals.

Acutaas Chemicals Share Price

2393.40 -17.75 (-0.74%)
21-Apr-2026 13:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.60
Dr. Reddys Lab 1220.90
Cipla 1231.05
Zydus Lifesciences 927.40
Lupin 2324.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×